Skip to content
Open access

43 Determinants of Survival Following Re-resection for Recurrent High-Grade Glioma: A Single-Centre Retrospective Cohort Study

Aug 2026 · Neuro-Oncology · 0 citations

Abstract

Evidence is limited to define which patients derive meaningful survival benefit from re-resection of recurrent high-grade glioma (HGG). This study aimed to identify clinical determinants of overall survival (OS) in a cohort of patients undergoing surgical resection for HGG, with secondary analysis of the re-resection subgroup. A retrospective single-centre analysis was performed on consecutive patients undergoing HGG resection from 2020-2021. OS was calculated from the date of first resection to death or censorship. A multivariate Cox proportional hazards (PH) model was implemented to identify independent predictors of OS. A secondary Cox PH model was performed in the re-resection subgroup, with OS calculated from the date of second resection. Of 70 patients identified, 18 (25.7%) underwent re-resection for recurrent disease. In the whole-cohort multivariate model, re-resection was associated with a 69% reduction in hazard of death (HR 0.306, p = 0.001). Median OS from the second resection was 12.9 months (IDH wildtype: 12.2 months; mutant: 35.1). No independent predictors of post-re-resection survival reached statistical significance. However, clinically relevant trends were observed: adjuvant therapy (HR 0.306, p = 0.169), and absence of surgical complications following re-resection trended towards improved survival (HR 0.648, p = 0.460). Greater extent of second resection is modestly protective (HR 0.991 per %, p = 0.596). Conversely, IDH wildtype (HR 1.963, p = 0.622) and higher ASA grade at re-resection (HR 1.256, p = 0.663) trended towards poorer survival. Re-resection was the strongest independent predictor of improved survival in this cohort of high-grade glioma patients. Due to limited sample size in the current re-resection subgroup, no independent factor predicted post-re-resection survival. Prospective studies with larger cohorts are warranted to confirm meaningful selection criteria.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.